Low dose chemotherapy is sometimes combined with insulin potentiation therapy (IPT) to treat various types of cancers. It has been studied in human subjects who are suffering from prostate cancer.
In one study (1), 16 participants who were suffering from metastatic prostate cancer and who had failed other forms of treatment for prostate cancer, such as androgen blockade and castration, were studied. Some participants received low-dose chemotherapy with a luteinizing hormone-releasing hormone agonist (LHRH agonist), while others received low dose chemotherapy using a different chemotherapy agent.
They had moderate success with these forms of treatment. Half of all patients were partially treated, while a quarter of patients were completely stabilized. The rest progressed and were not helped at all with this form of therapy. Researchers expect that using low-dose chemotherapy with IPT might be effective in treating prostate cancer when more research is done.
- Damyonov C, et al. Low-Dose Chemotherapy with Insulin (Insulin Potentiation Therapy) in Combination with Hormone Therapy for Treatment of Castration-Resistant Prostate Cancer. ISRN Urology. Published online 2012 May 8. doi: 10.5402/2012/140182.
Dr. Adem Gunes